Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory
 
logn  

username:

 password:

 

  home
 
  Products Center
  API
Paclitaxel (Natural) USP31
Paclitaxel (Semi-synthetic) USP31
Docetaxel Anhydrous
Docetaxel Trihydrate
Irinotecan HCl Trihydrate 99.5%
Palonosetron Hydrochloride
Etoposide USP31
Fludarabine Phosphate USP31
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
more...
  Side chain for Paclitaxel and Docetaxel
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
Ethyl (2R,3S)-3-Phenylisoserine Ester
more...
  N-1 stage of Paclitaxel and Docetaxel
7-Triethylsilyl-13-[(4S,5R)-4,5-dihydro-2
7,10-di-Troc-Docetaxel
more...
 
 
Your location:Home>>R & D >>Patents
 
 

Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns two patents as below:

 A Synthetic method of Docetaxel
Patent Number: ZL 2006 1 0116735.6
Issue Date: 30 July, 2008

 A method of Extracting and Purifying 10- Deacetyl Baccatin III
Patent Number: ZL 03 1 29635.1
Issue Date: 18 May, 2005


Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development.


 
CopyRight(C)2006,Shanghai Jinhe Bio-Technology Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE